comparemela.com

Akthelia Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Antibiotic Resistance Markets Therapeutics, by Pathogen and

Dublin, May 27, 2024 (GLOBE NEWSWIRE) The

Theravance biopharmaProcarta biosystemsAmpliphi biosciencesEligo bioscienceJohnson janssenBioversys gmbBiofilm pharmaAkthelia pharmaAbsynth biologicsXellia pharmaceutialsRedhill biopharmaPherecydes pharmaDeinobiotics deinoveQpex biopharmaAridis pharmaceuticals incContrafect corporation

Global Antibiotic Resistance Market Research Report 2023-2027: Search for Alternatives to Antibiotics Creates New Goldrush

/PRNewswire/ The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &.

United statesAkthelia pharmaXellia pharmaceutialsQpex biopharmaRedhill biopharmaBiofilm pharmaTheravance biopharmaProcarta biosystemsAbsynth biologicsEligo bioscienceLaura woodPherecydes pharmaJohnson janssenBioversys gmbDeinobiotics deinoveAmpliphi biosciences

Global Antibiotic Resistance Markets, 2023-2027: Beyond

Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) The

United statesQpex biopharmaXellia pharmaceutialsProcarta biosystemsBiofilm pharmaJohnson janssenTheravance biopharmaAbsynth biologicsBioversys gmbDeinobiotics deinoveEligo bioscienceRedhill biopharmaAkthelia pharmaPherecydes pharmaAmpliphi biosciencesCo ltd

Icelandic deep tech startup and the University of Iceland secure a €6M EU Horizon grant to combat antimicrobial resistance (AMR)

Reykjavik-based biopharma startup Akthelia Pharmaceuticals and the University of Iceland have been awarded a €6 million EU Horizon Grant to fund the IN-ARMOR

Egill massonGudmundur gudmundssonAkthelia pharmaUniversity of icelandAkthelia pharmaceuticalsProfessor gudmundur gudmundssonCell biology

Akthelia, University of Iceland receive funds for IN-ARMOR project

Akthelia Pharmaceuticals, along with the University of Iceland, has received a €6m EU Horizon Grant for the IN-ARMOR project.

Egill massonGerd altmannAkthelia pharmaAkthelia pharmaceuticalsEuropean union eu horizon grantWorld health organisationUniversity of icelandEuropean unionHorizon grant

vimarsana © 2020. All Rights Reserved.